MedPath

Health Effects From Removal of Amalgam Restorations in Patients With Symptoms Allegedly Related to Dental Amalgam

Phase 4
Completed
Conditions
Adverse Effects
Dental Restoration, Permanent
Interventions
Procedure: Removal of dental amalgam restorations
Registration Number
NCT00346944
Lead Sponsor
University of Bergen
Brief Summary

The aim of the project is to study changes in symptom load after removal of all dental amalgam restorations in patients with symptoms allegedly related to amalgam.

Detailed Description

Patients referred from dentists and physicians in the period 1993 to 1999 to the Dental Biomaterials Adverse Reaction Unit, Department of Health, UNIFOB AS, for symptoms related to amalgam restorations are randomized into treatment group (n=20) or reference group (n=20). All patients in the treatment group are followed 3, 12, 36 and 60 months after completion of amalgam removal with questionnaires on health outcomes, Minnesota Multiphasic Personality Inventory-2 (MMPI-2) and laboratory tests.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Referred for examination of general health complaints related to amalgam
  • Health complaints from at least three different organ systems
  • Dental amalgam restorations present
  • Data available on concentration of mercury in blood and urine at the initial examination
  • Patient agreed to be contacted after the examination
Exclusion Criteria
  • Serious disease (incl. severe allergy to foodstuff and severe rheumatoid arthritis)
  • Mental instability or psychiatric disease
  • Cases with complicated dental rehabilitation (incl. bridge prostheses)
  • Allergy to dental replacement materials
  • Severe periodontitis
  • High caries activity

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Treatment groupRemoval of dental amalgam restorations-
Primary Outcome Measures
NameTimeMethod
Changes of subjective health complaintsFive years
Changes over time of the MMPI-profileFive years
Quality of life improvementFive years
Secondary Outcome Measures
NameTimeMethod
Reduction of mercury in blood serumOne year

Trial Locations

Locations (1)

UNIFOB AS, Dental Biomaterials Adverse Reaction Unit

🇳🇴

Bergen, Norway

© Copyright 2025. All Rights Reserved by MedPath